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Risk Factors for Surgical Site Infection
Following Orthopaedic Spinal Operations
By Margaret A. Olsen, PhD, MPH, Jeffrey J. Nepple, MD, K. Daniel Riew, MD, Lawrence G. Lenke, MD,
Keith H. Bridwell, MD, JennieMayfield, BSN, MPH, CIC, and Victoria J. Fraser, MD
Investigation performed at Washington University School of Medicine, St. Louis, Missouri
Background: Surgical site infections are not uncommon following spinal operations, and they can be associated with
serious morbidity, mortality, and increased resource utilization. The accurate identification of risk factors is essential to
develop strategies to prevent these potentially devastating infections. We conducted a case-control study to determine
independent risk factors for surgical site infection following orthopaedic spinal operations.
Methods: We performed a retrospective case-control study of patients who had had an orthopaedic spinal operation
performed at a university-affiliated tertiary-care hospital from 1998 to 2002. Forty-six patients with a superficial, deep,
or organ-space surgical site infection were identified and compared with 227 uninfected control patients. Risk factors
for surgical site infection were determined with univariate analyses and multivariate logistic regression.
Results: The overall rate of spinal surgical site infection during the five years of the study was 2.0% (forty-six of 2316).
Univariate analyses showed serum glucose levels, preoperatively and within five days after the operation, to be
significantly higher in patients in whom surgical site infection developed than in uninfected control patients. Inde-
pendent risk factors for surgical site infection that were identified by multivariate analysis were diabetes (odds ratio =
3.5, 95% confidence interval = 1.2, 10.0), suboptimal timing of prophylactic antibiotic therapy (odds ratio = 3.4, 95%
confidence interval = 1.5, 7.9), a preoperative serum glucose level of >125 mg/dL (>6.9 mmol/L) or a postoperative
serum glucose level of >200 mg/dL (>11.1 mmol/L) (odds ratio = 3.3, 95% confidence interval = 1.4, 7.5), obesity
(odds ratio = 2.2, 95% confidence interval = 1.1, 4.7), and two or more surgical residents participating in the operative
procedure (odds ratio = 2.2, 95% confidence interval = 1.0, 4.7). A decreased risk of surgical site infection was
associated with operations involving the cervical spine (odds ratio = 0.3, 95% confidence interval = 0.1, 0.6).
Conclusions: Diabetes was associated with the highest independent risk of spinal surgical site infection, and an
elevated preoperative or postoperative serum glucose level was also independently associated with an increased risk
of surgical site infection. The role of hyperglycemia as a risk factor for surgical site infection in patients not previously
diagnosed with diabetes should be investigated further. Administration of prophylactic antibiotics within one hour
before the operation and increasing the antibiotic dosage to adjust for obesity are also important strategies to decrease
the risk of surgical site infection after spinal operations.
Level of Evidence: Prognostic Level III. See Instructions to Authors for a complete description of levels of evidence.
S
urgical site infection is the most common hospital-
acquired infection that occurs in the early postoperative
period in surgical patients1. United States hospitals par-
ticipating in the National Nosocomial Infections Surveillance
(NNIS) System, a voluntary performance-measurement system
operated by the Centers for Disease Control and Prevention
(CDC), monitor rates of surgical site infection following
laminectomy and spinal arthrodesis. The most recent NNIS
Disclosure: In support of their research for or preparation of this work, one or more of the authors received, in any one year, outside funding or grants in
excess of $10,000 from the Centers for Disease Control and Prevention (UR8/CCU715087), the National Institutes of Health/National Institute of
Allergy and Infectious Diseases (Career Development Awards [K01AI065808 and K24AI067794]), and the Washington University School of Medicine
Summer Research Program National Institutes of Health training grant (5T35HL007815). Neither they nor a member of their immediate families
received payments or other benefits or a commitment or agreement to provide such benefits from a commercial entity. No commercial entity paid or
directed, or agreed to pay or direct, any benefits to any research fund, foundation, division, center, clinical practice, or other charitable or nonprofit
organization with which the authors, or a member of their immediate families, are affiliated or associated.
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summary by the CDC reported a 1.25% rate of surgical site
infection after laminectomy and a 2.1% rate following spinal
arthrodesis2. Rates of surgical site infection reported from in-
dividual institutions have ranged from 0% to 15%, depending
on the reason for the operation, the site, the approach, and the
use of instrumentation3-8.
A wide variety of risk factors for surgical site infection
after spinal operations have been reported in the literature.
However, many of the studies were limited by their relatively
small sample size, which restricts the ability to perform multi-
variate analyses to identify independent risk factors for infec-
tion9. Another potential problem with the currently available
literature is the use of nonstandard definitions and variable
time-frames for surveillance of surgical site infection, which
makes comparison of results between studies difficult. A third
problem is that many studies included only a small fraction
of all potential risk factors for surgical site infection in their
analyses. In order to accurately identify independent risk fac-
tors for surgical site infection, studies with relatively large
numbers of patients with surgical site infection need to
be performed, with the investigators including a wide variety
of potential risk factors, using standard accepted definitions
of surgical site infection, and controlling for the occurrence of
multiple risk factors within individual patients by performing
multivariate statistical analyses.
We recently described independent risk factors for sur-
gical site infection following spinal operations performed by
neurosurgeons10. In that study, we found postoperative in-
continence, a posterior surgical approach, an operation for
tumor resection, and morbid obesity to be associated with an
increased risk of surgical site infection in a multivariate anal-
ysis of a population of patients treated with spinal surgery in
which the overall rate of surgical site infection was 2.76%. We
undertook a subsequent retrospective case-control study to
determine if we could identify unique risk factors for surgical
site infection in patients undergoing orthopaedic spinal sur-
gery. We suspected that the risk factors in our orthopaedic
patient population might be different from those in the neu-
rosurgical spine population. This report describes risk factors
for surgical site infection following spinal operations per-
formed by orthopaedic surgeons over a five-year time period at
a tertiary-care university-affiliated hospital.
Materials and Methods
Study Design and Inclusion and Exclusion Criteria
Weperformed a retrospective nested case-control study ata tertiary-care university-affiliated hospital after ob-
taining approval from our institutional review board. Patients
who had undergone a spinal operation were identified by
querying the hospital Medical Informatics database for ad-
missions coded with International Classification of Diseases,
Ninth Revision, Clinical Modification (ICD-9-CM) procedure
codes for laminectomy (03.02 and 03.09), discectomy (80.50
and 80.51), and/or spinal arthrodesis (81.00 to 81.09) from
January 1998 through December 2002. Eligible operations
were restricted to those performed by an orthopaedic surgeon
at our institution in patients fifteen years of age or older (n =
2316). Other spinal procedures and operations performed by
neurosurgeons were excluded. In addition, operations per-
formed in patients with an admission ICD-9-CM diagnosis
code for intraspinal abscess (324.1), osteomyelitis (730.08,
730.18, and 730.28), or surgical site infection (998.5, 998.51,
and 998.59) were excluded. The basic demographic and sur-
gical characteristics of the cohort are shown in Table I.
Identification of Surgical Site Infection
Patients likely to have a surgical site infection were identified
with use of a combination of ICD-9-CM diagnosis codes
suggestive of infection, a readmission diagnosis of infection,
and/or positive microbiological cultures of specimens from the
wound. The ICD-9-CM codes used as indicators of possible
surgical site infection included codes for surgical site infection
(998.5, 998.51, and 998.59), cellulitis (682.1, 682.2, and 682.6),
osteomyelitis (730.08 and 730.28), dehiscence (998.3 and
998.32), or intraspinal abscess (324.1). The medical records of
patients with indicators of potential surgical site infection
during the hospitalization for the initial surgery or at the time
of readmission to the hospital within one year after the oper-
ation were reviewed for recorded signs and symptoms of
surgical site infection. In addition, all microbiology, radiology,
pathology, and operative reports were reviewed to determine if
the CDC/NNIS definitions of surgical site infection were met11.
Included in the CDC/NNIS definition is any physician diag-
nosis of surgical site infection; therefore, if the spine surgeon
or consulting infectious disease physician noted the presence
of infection in the medical record, that was considered proof
of surgical site infection. The CDC/NNIS definitions include
deep surgical site and organ-space infections if they had an
onset within thirty days after the operation (or within one year
if the operation included placement of an implant) and su-
perficial surgical site infection with an onset within thirty days
after the operation11. Deep surgical site infection involved deep
soft tissues (fascia and muscle), whereas organ-space infections
included osteomyelitis, meningitis, and empyema (following
TABLE I Demographics and Surgical Characteristics of the
2316 Patients Treated with Orthopaedic Spinal
Surgery from 1998 to 2002
Characteristic
Mean age (range) (yr) 52.4 (15.2-94.4)
Female gender (no.) 1213 (52.4%)
Mean body mass index (range) (kg/m2) 28.4 (16.1-57.6)
Type of surgery (no.)
Laminectomy only (including laminoplasty) 326 (14.1%)
Discectomy ± laminectomy 309 (13.3%)
Arthrodesis ± instrumentation 1657 (71.5%)
Instrumentation only 24 (1.0%)
Admissions with >1 spinal op. (no.) 87 (3.8%)
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anterior thoracic procedures). All surgical site infections were
confirmed by the nurse infection-control practitioner re-
sponsible for spine operations (J.M.).
Forty-six patients had a confirmed surgical site infection
involving the spinal incision. In addition, four patients with an
ICD-9-CM code indicating surgical site infection were ex-
cluded because the infection involved only the bone-graft
donor site (the hip), and three were excluded because the in-
fection was at a distant site (unrelated to the spine operation).
In five patients with an ICD-9-CM code indicating surgical site
infection at the time of readmission, the infection did not meet
the CDC/NNIS definition of surgical site infection; those pa-
tients were excluded as well. The medical records of 227
control patients without a surgical site infection, selected with
use of a random-number generator from the cohort of patients
treated with an orthopaedic spinal operation at our institution
from 1998 to 2002, were reviewed. This resulted in approxi-
mately five uninfected control patients for each patient with a
surgical site infection. Fifteen control patients without a surgical
site infection had had a two-stage spinal operation performed
on separate days during the surgical admission. In order to per-
form subsequent analyses that included surgical variables at the
patient level, one of the two staged operations was randomly
selected for all subsequent analyses. One patient with a surgical
site infection had been scheduled to undergo two staged oper-
ations, but an infection was diagnosed during the second op-
eration. Since the surgical site infection was attributed to the
first operation, that operation was used for the analysis.
Data Collection
All data, including the type, approach, and level of the oper-
ative procedure; potential risk factors for surgical site infection;
and signs and symptoms of surgical site infection were col-
lected from the medical records by two investigators (J.J.N. and
M.A.O.), using a standardized data collection form. In addi-
tion, the orthopaedic spine surgeons’ database was used to
verify the type of operative procedure, approach, level, source
of bone graft, and use of instrumentation. Potential risk factors
for surgical site infection included a wide variety of demo-
graphic, comorbid, operative, and postoperative variables,
derived primarily from our previous study of surgical site in-
fection after spinal operations10 and a thorough review of the
literature. Data from the first fifty medical records and a
random subset of the remaining records were collected in
duplicate, to ensure comparability of collected data between
the two investigators. Extensive logic checks were performed to
identify illogical or impossible data, with resolution of results
by repeat review of the medical and computer records.
Data Analysis
Associations between surgical site infection and potential risk
factors were analyzed with use of the chi-square test and the
calculation of an odds ratio and 95% confidence intervals.
Significant differences between continuous variables were de-
termined with the t test or the Mann-Whitney U test. A p value
of <0.05 was considered significant. Multivariate logistic re-
gression analysis was used to identify independent risk factors
for surgical site infection. Variables eligible for inclusion in the
multivariate models included those reported to be associated
with an increased risk of surgical site infection in the literature,
those with clinical and/or biologic plausibility, and those with
p values of <0.20 in the univariate analyses. After identification
of the main effects in the logistic regression models, all clini-
cally meaningful two-way interaction factors were tested in the
models. The final model(s) were checked for goodness of fit
with the Hosmer and Lemeshow test and by colinearity and
residuals diagnostics, to ensure they were well specified and fit
the data12.
Results
The incidence of surgical site infection following ortho-paedic spinal operations performed from 1998 to 2002
was 2.0% (forty-six of 2316). Twenty (43%) of the forty-six
infections were classified as deep incisional (involving fascia
and/or muscle); eight (17%), as organ space (involving an
anatomic space opened during the surgery other than the in-
cision, and including osteomyelitis, empyema, and meningi-
tis); and eighteen (39%), as superficial incisional (involving
only skin or subcutaneous tissues). The median time from the
operation to the diagnosis of the infection was eleven days,
with a minimum of two days and a maximum of 236 days for a
patient with osteomyelitis. All surgical site infections were
treated with intravenous antibiotics in the hospital, and thirty-
six (78%) of the forty-six patients had a repeat operation to
treat the infection. Seven of the ten patients who did not have a
repeat operation were diagnosed with a superficial surgical site
infection and responded to intravenous antibiotic therapy.
The patient-level factors that were found to be associ-
ated with a significantly increased risk of surgical site infec-
tion in the univariate analysis are shown in Table II. They
included diabetes, an elevated serum glucose level, a peri-
operative transfusion, postoperative incontinence (bowel or
bladder, or both), and any incontinence (preoperative or post-
operative). There was no difference in the risk of surgical site
infection between patients with insulin-dependent diabetes
mellitus and diabetic patients treated with oral therapy (a
surgical site infection developed in two of four insulin-
dependent diabetic patients compared with twelve of twenty-
two diabetic patients treated with oral therapy only). Only
three diabetic patients were managed solely with diet, and a
surgical site infection did not develop in any of them. Obesity,
defined as a body mass index of 30 to 35 kg/m2, was associated
with an increased risk of surgical site infection, although
morbid obesity (a body mass index of >35 kg/m2) had only a
marginal association with surgical site infection (p = 0.075).
Diagnoses of herniated disc and nerve root compression were
associated with a significantly lower risk of surgical site in-
fection, whereas a diagnosis of vertebral fracture was associated
with a higher risk of surgical site infection. More severe illness,
as indicated by an American Society of Anesthesiologists score
of 3 or 4, was associated with an increased risk of surgical site
infection. Malnutrition, defined as a serum albumin level of
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<2.5 g/dL (<25 g/L) in blood collected during the most recent
clinic visit within thirty days before the operation or the sur-
gical admission, was not associated with surgical site infection
(p = 1.000).
The univariate associations of selected surgical-level
factors and the risk of spinal surgical site infection are shown
in Table III. Operations on the cervical spine, intravenous use
of steroids intraoperatively, and use of cefazolin alone for in-
fection prophylaxis were all associated with a significantly
lower risk of surgical site infection. Performance of the oper-
ation through a posterior approach was associated with a
significantly increased risk of surgical site infection. There was
no association between surgical site infection and the use of
bone graft (p = 0.479), the use of instrumentation (p = 0.901),
or a previous operation at the same site (p = 0.775). Subop-
timal timing of prophylactic antibiotics therapy, defined as the
administration of cefazolin more than sixty minutes before the
incision or any antibiotic(s) first given after the incision, was
associated with an increased risk of surgical site infection, as
was a suboptimal dose of prophylactic cefazolin in obese pa-
tients (1 g of cefazolin in persons with a body mass index of
>30 kg/m2). Other operative variables associated with an in-
creased risk of surgical site infection included aminoglycoside
prophylaxis, irrigation of the surgical wound with an antibiotic
solution (cefazolin or bacitracin), use of a drain for three or
more days after the operation, and two or more surgical resi-
dents participating in the operation.
The median duration of the operation was significantly
longer (181 compared with 150 minutes, p = 0.009) and the
median estimated blood loss was significantly higher (275 mL
compared with 150 mL, p = 0.033) in the patients with a surgical
site infection than in the control patients. As shown in Table III,
an extensive operation involving seven or more intervertebral
levels was associated with a higher risk of surgical site infection
than was an operation involving only one intervertebral level.
This finding is consistent with the association between the du-
ration of the operation and the risk of surgical site infection
since the median number of intervertebral levels involved in
operations with a duration of longer than the 75th percentile
was four compared with two levels for operations lasting less
than the 75th percentile. Participation in the operation by two or
more surgical residents was also associated with a significantly
longer duration of the operation and an operation involving
a larger number of intervertebral levels (p < 0.001 for both). Of
all of the patient-level and operative characteristics, only a body
mass index of 30 to 35 kg/m2, diabetes, and transfusion of
packed red blood cells or platelets met the criterion for signifi-
cance after correction for multiple testing (a = 0.001).
The association between preoperative and postoperative
serum glucose levels and surgical site infection was assessed.
The results of serum glucose tests were not available for all
patients at all time-points, so the number of subjects varied
depending on the timing of the glucose testing. Patients with a
surgical site infection had significantly higher serum glucose
TABLE II Univariate Comparisons of Individual Risk Factors in Patients with and without Surgical Site Infection Following
Orthopaedic Spinal Operations
Patient-Level Characteristics
No. (%) of
Patients with Surgical
Site Infection (N = 46)
No. (%) of Uninfected
Patients (N = 227)
Odds Ratio (95%
Confidence Interval) P Value
Body mass index
Normal (£25 kg/m2) 9 (20) 84 (37) 1.0
Overweight (>25 and <30 kg/m2) 11 (24) 77 (34) 1.3 (0.5, 3.4) 0.546
Obese (‡30 and £35 kg/m2) 18 (39) 37 (16) 4.5 (1.9, 11.0) 0.001
Morbidly obese (>35 kg/m2) 8 (17) 29 (13) 2.6 (0.9, 7.3) 0.075
Diabetes and hyperglycemia
Neither (no diabetes or hyperglycemia) 20 (43) 179 (79) 1.0
Serum glucose >75th percentile 12 (26) 33 (15) 3.3 (1.5, 7.3) 0.004
Diabetes 14 (30) 15 (7) 8.4 (3.5, 19.8) <0.001
Diagnoses
Herniated disc 6 (13) 63 (28) 0.4 (0.2, 1.0) 0.036
Fracture 6 (13) 9 (4) 3.6 (1.2, 10.8) 0.025
American Society of Anesthesiologists class 3 or 4 22 (48) 59 (26) 2.6 (1.4, 5.0) 0.003
Nerve root compression 22 (48) 153 (67) 0.4 (0.2, 0.8) 0.012
Transfusion
Cell Saver or autologous blood 10 (22) 35 (15) 2.2 (0.9, 5.0) 0.071
Packed red blood cells or platelets 15 (33) 33 (14.5) 3.4 (1.6, 7.4) 0.001
Postoperative incontinence 8 (17) 14 (6) 3.2 (1.3, 8.2) 0.018
Preoperative or postoperative incontinence 13 (28) 27 (12) 2.9 (1.4, 6.2) 0.004
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levels at the time of the most recent preoperative clinic testing
(within thirty days before the surgical admission) and signif-
icantly higher postoperative serum glucose levels (with use of
the highest value within five days after the operation for the
analysis) (Table IV). The blood collected for glucose testing at
the most recent preoperative clinic visit and the postoperative
blood were obtained randomly, since patients had not been
told to fast.
Since few patients (20%) had serum glucose tests within
twenty-four hours before the operation, the results of the
random preoperative laboratory testing were combined with
the results of fasting serum glucose tests performed on the day
before the operation to create a preoperative serum glucose
variable (with the most recent result used if both had been
obtained). The 75th percentile for this combined preoperative
serum glucose level was 125 mg/dL (6.9 mmol/L), and the 75th
TABLE III Univariate Comparisons of Surgical Risk Factors in Patients with and without Surgical Site Infection Following
Orthopaedic Spinal Operations
Operative Characteristics
No. (%) of
Patients with Surgical
Site Infection (N = 46)
No. (%) of Uninfected
Patients (N = 227)
Odds Ratio (95%
Confidence Interval) P Value
Cervical level 11 (24) 97 (43) 0.4 (0.2, 0.9) 0.017
Posterior approach 42 (91) 172 (76) 3.4 (1.2, 9.8) 0.020
Suboptimal timing of prophylactic antibiotic therapy* 15 (33) 31 (14) 3.1 (1.5, 6.3) 0.002
Suboptimal dosage of prophylactic antibiotic† 20 (43.5) 51 (22.5) 2.7 (1.4, 5.1) 0.003
Only cefazolin used as prophylactic antibiotic 24 (52) 168 (74) 0.4 (0.2, 0.7) 0.003
Aminoglycoside used as prophylactic antibiotic 17 (37) 41 (18) 2.7 (1.3, 5.3) 0.004
Intravenous steroids during operation 8 (17) 85 (37) 0.4 (0.2, 0.8) 0.009
Wound irrigated with antibiotic-containing solution 40 (87) 162 (71) 2.7 (1.1, 6.6) 0.028
No. of intervertebral levels
1 10 (22) 83 (37) 1.0
2-3 21 (46) 94 (41) 1.9 (0.8, 4.2) 0.135
4-6 7 (15) 30 (13) 1.9 (0.7, 5.5) 0.218
‡7 8 (17) 20 (9) 3.3 (1.2, 9.5) 0.025
Duration of operation >75th percentile‡ 18 (39) 49 (22) 2.4 (1.2, 4.6) 0.012
Hemovac drain placed 26 (56.5) 95 (42) 1.8 (1.0, 3.4) 0.068
Drains in place ‡3 days 33 (72) 108 (48) 2.8 (1.4, 5.6) 0.003
‡2 resident surgeons 32 (70) 109 (48) 2.5 (1.3, 4.9) 0.008
*Cefazolin given more than sixty minutes before the incision or after the incision, or another antibiotic given after the incision. Two hundred and
twenty-nine (84%) of the 273 patients received prophylactic cefazolin, alone (192), in combination with an aminoglycoside (thirty-four), or in
combination with another antibiotic (three). †One gram of cefazolin used as a prophylactic antibiotic in patients with a body mass index of ‡30.0
kg/m2. ‡The 75th percentile for fusion was 310.5 minutes; the 75th percentile for non-fusion operations was 145 minutes.
TABLE IV Association Between an Elevated Serum Glucose Level and the Risk of Surgical Site Infection Following
Orthopaedic Spinal Operations
Glucose Level (mg/dL*)
Patients with Surgical Site Infection Uninfected Patients
Mean ± Standard
Deviation
Median
(Range)
Mean ± Standard
Deviation
Median
(Range) P Value†
At most recent preoperative visit (n = 189) 131 ± 49.4 108 (73-267) 101 ± 38.8 92 (56-300) <0.001
Within 24 hr before operation (n = 53) 154 ± 38.4 144 (117-239) 126 ± 47.9 116 (72-311) 0.122
Within 5 days after operation (n = 146) 206 ± 80.9 187 (109-576) 169 ± 56.7 156 (99-460) 0.003
*The conventional unit (mg/dL) is converted to the SI unit (mmol/L) by multiplying by 0.0555. †Derived with the Mann-Whitney U test.
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percentile for the random postoperative serum glucose level
was 200 mg/dL (11.1 mmol/L). When the serum glucose levels
were categorized according to these cutoffs, a preoperative
level of >125 mg/dL was associated with a 5.3-fold increased
risk of surgical site infection, and any postoperative glucose
level (within five days after the operation) of >200 mg/dL was
associated with a 2.9-fold increased risk of surgical site infec-
tion (Table V). Either a preoperative or any postoperative
serum glucose level of >75th percentile was associated with a
4.7-fold increased risk of surgical site infection.
We also analyzed the association of the preoperative
glucose level with surgical site infection after taking into ac-
count receipt of total parenteral nutrition before the surgery.
Twenty-seven patients received total parenteral nutrition
during their hospital stay, although only six of the twenty-
seven patients received total parenteral nutrition before the
eligible operation. Using a cutoff of 200 mg/dL for the pre-
operative serum glucose level in patients receiving total par-
enteral nutrition instead of 125 mg/dL decreased the effect size
for the association of the preoperative glucose level and the risk
of surgical site infection only slightly (odds ratio = 4.7, p <
0.001, compared with odds ratio = 5.3; Table V).
The results of the multivariate analysis to identify in-
dependent risk factors for spinal surgical site infection are
shown in Table VI. Diabetes had the strongest association with
surgical site infection, with an adjusted odds ratio of 3.5 after
we controlled for the other variables in the model. Other
variables that remained independently associated with an in-
creased risk of surgical site infection included suboptimal
timing of prophylactic antibiotic therapy (odds ratio = 3.4), an
elevated serum glucose level (a preoperative random or fasting
serum glucose level of >125 mg/dL or a postoperative random
serum glucose level of >200 mg/dL) (odds ratio = 3.3), obesity
(odds ratio = 2.2), and participation in the operation by two or
more surgical residents (odds ratio = 2.2). An operation in-
volving cervical levels was associated with a significantly lower
risk of spinal surgical site infection (odds ratio = 0.3). The
model had good predictive ability, with a c-statistic of 0.807.
Discussion
This study extends the work that we did previously to de-termine independent risk factors for surgical site infection
after spinal operations10. We performed this second study
to determine whether there were unique risk factors in our
patients undergoing orthopaedic spinal surgery as compared
with patients undergoing spinal neurosurgery based on un-
derlying differences in the patient populations. An additional
rationale for undertaking a second study was to collect more
detailed data regarding some potential risk factors, such as
hyperglycemia, drain utilization, and local and systemic steroid
use, than had been collected in our initial study. In the present
study, diabetes, suboptimal timing of prophylactic antibiotic
TABLE V Risk of Spinal Surgical Site Infection According to Categorization of Serum Glucose Results
Glucose Level* (mg/dL [mmol/L])
No. of Patients with
Surgical Site Infection/
No. Tested (%)
No. of Uninfected Patients/
No. Tested (%)
Odds Ratio (95%
Confidence Interval) P Value
Preoperative† >125 (>6.9) 20/39 (51) 30/182 (16) 5.3 (2.5, 11.2) <0.001
Postoperative >200 (>11.1) 14/35 (40) 21/111 (19) 2.9 (1.2, 6.5) 0.011
Preoperative >125 or postoperative >200 25/45 (56) 45/215 (21) 4.7 (2.4, 9.3) <0.001
*These values represent the 75th percentiles, which were used as the cutoffs in the analysis. †The result of testing twenty-four hours before the
operation, if performed, or the result of the most recent preoperative laboratory test.
TABLE VI Multivariate Logistic Regression Model for the Development of Spinal Surgical Site Infection*
Risk Factor
Adjusted Odds Ratios
(95% Confidence Interval) P Value
Diabetes 3.5 (1.2, 10.0) 0.020
Suboptimal timing of prophylactic antibiotic therapy 3.4 (1.5, 7.9) 0.005
Elevated serum glucose level (>125 mg/dL [>6.9 mmol/L])
preoperatively or >200 mg/dL [>11.1 mmol/L]) postoperatively
3.3 (1.4, 7.5) 0.005
Obesity (body mass index >30.0 kg/m2) 2.2 (1.1, 4.7) 0.034
‡2 resident surgeons 2.2 (1.0, 4.7) 0.048
Operation involving cervical levels 0.3 (0.1, 0.6) 0.002
*The c-statistic for the model = 0.807. The Hosmer and Lemeshow goodness-of-fit chi-square p = 0.734 (7 degrees of freedom), and the
Nagelkerke R2 = 0.305.
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therapy, elevated serum glucose levels, obesity, and participa-
tion in the operation by two or more surgical residents were
found to be independently associated with infection involv-
ing the spinal incision after laminectomy, discectomy, and/or
spinal arthrodesis. Surgery at a cervical level was independently
associated with a significantly decreased risk of surgical site
infection following orthopaedic spinal operations.
Contrary to some reports in the literature, we found no
association between arthrodesis and an increased risk of sur-
gical site infection. Our hospital is a regional referral center for
spine operations, and it is likely that more complex laminec-
tomies and discectomies are performed at our institution than
at community or smaller tertiary-care hospitals. This is con-
sistent with our surgical site infection rates as compared with
the CDC/NNIS rates; the surgical site infection rate after
laminectomies and discectomies performed by orthopaedic
surgeons at our institution from 1998 to 2002 was 2.3%,
higher than the mean CDC/NNIS rate of 1.5%2. The surgical
site infection rate at our institution after orthopaedic spinal
arthrodeses was 1.9%, which is slightly lower than the mean
CDC/NNIS rate of 2.1%2.
Diabetes and Increased Risk of Surgical Site Infection
A diagnosis of diabetes was associated with the greatest in-
dependent risk of spinal surgical site infection, and elevated
serum glucose levels remained significantly associated with
surgical site infection after we controlled for diabetes and other
variables. To our knowledge, this is the first study to demon-
strate the independent risk of surgical site infection after spine
operations associated with hyperglycemia. Numerous authors
have found that the increased risk of deep sternal surgical site
infection following cardiac operations can be ameliorated in
diabetic patients by careful perioperative monitoring and
control of serum glucose levels13-15. We are aware of no studies
on the effects of such a strategy for patients undergoing spinal
surgery, although the univariate association of diabetes with
spinal surgical site infection has been reported in a number of
studies8,16-19. We previously found an association between peri-
operative hyperglycemia and surgical site infection following
spinal neurosurgery10. In our previous study, this association did
not remain significant in the multivariate analysis, possibly
because of a more strict definition of hyperglycemia (a glucose
level of >200 mg/dL during the surgical admission) compared
with that used in the current study. Confirmation of these
findings might lead to studies of intensive perioperative glucose
control in patients with diabetes undergoing orthopaedic op-
erations. Additional study is needed to confirm the risk of
surgical site infection due to hyperglycemia in patients not
previously diagnosed with diabetes.
Other Independent Predictors of Surgical Site Infection
Suboptimal timing of prophylactic antibiotic therapy was as-
sociated with a 3.4-fold increased risk of surgical site infection
in the multivariate model, a finding very similar to the results
reported by Classen et al.20. Because of the relatively small size
of this case-control study, we included receipt of a cephalo-
sporin more than one hour before the incision or any pro-
phylactic antibiotic given after the incision in the ‘‘suboptimal’’
category. The current recommendation for antibiotic pro-
phylaxis for neurosurgical and orthopaedic procedures is for
1 to 2 g of cefazolin to be given in the hour before the incision
in nonallergic patients21; thus, administration of an antibiotic
outside of this period would be considered suboptimal. The
finding of an increased risk of surgical site infection associated
with prophylactic antibiotic administration outside of the one-
hour window before the incision supports the recommen-
dations of the Surgical Care Improvement Project (SCIP) to
establish quality-improvement measures to ensure timely ad-
ministration of prophylactic antibiotics22.
Obesity was associated with an increased risk of spinal
surgical site infection in this study, a finding similar to those
after other operations11,23. The SCIP advisory panel recom-
mends a 2-g dose of cefazolin for prophylaxis in patients who
weigh ‡80 kg24. We could not accurately determine the effect of
increased cefazolin dosage on the risk of surgical site infection
in obese persons because of the small number of obese persons
who were given a 2-g dose. However, given the minimal side
effects of cefazolin in nonallergic patients, it appears reason-
able to give 2 g to all patients weighing ‡80 kg to decrease the
risk of surgical site infection associated with obesity.
Participation in the operative procedure by two or more
surgical residents was also associated with an increased risk of
surgical site infection. We assume that this variable was a proxy
for the duration of the operation and the complexity of the
operative procedure. We could not determine from the chart
review if the residents were present at the same time or moved
in and out of the operating room.
An operation at the cervical level was independently
associated with a decreased risk of surgical site infection.
Zeidman et al. previously reported a low rate of surgical site
infection following cervical spinal operations25. In our previous
study of spinal operations by neurosurgeons, we identified the
posterior surgical approach as a risk factor for surgical site
infection10. The posterior approach may not have remained
independently associated with an increased risk of surgical site
infection in the present study because of the inclusion of cer-
vical operations in the model and the relatively small number
of anterior operations.
Limitations and Strengths of This Study
The observational nature of this study precluded complete
analysis of somepotentially important risk factors for surgical site
infection, such as malnutrition. The serum albumin level was
measured at the discretion of the operating surgeon and was
therefore not available for all patients. The analyses of serum
glucose levels were also hampered by incomplete testing. It was
thus not possible to determine if the risk of surgical site infection
associated with persistently high serum glucose levels was higher
than that associated with only a single high value. Sequential
serum glucose testing needs to be performed before and after
spinal operations in order to more accurately determine the as-
sociation between hyperglycemia and surgical site infection.
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The strengths of this study include the wide variety of
potential risk factors that were analyzed and the relatively large
number of patients with spinal surgical site infection com-
pared with the numbers in most studies of this complication.
We used multivariate logistic regression analysis to determine
independent risk factors for surgical site infection, which is
particularly important when determining the magnitude of
risk associated with factors, such as diabetes and obesity, that
tend to cluster within individual patients26. We extracted data
for many patient and surgical risk factors, including the type
and duration of use of surgical drains, irrigant solutions,
prophylactic antibiotics, and serum glucose levels, in order to
perform detailed analyses of these variables. To our knowledge,
this is the most in-depth and comprehensive analysis of risk
factors for surgical site infection following spinal operations
that has been published.
Additional studies are warranted to determine whether
careful monitoring and control of serum glucose levels in the
perioperative period are associated with a decreased risk of
infection following spinal operations. While the risk of sur-
gical site infection can never be reduced to zero, establishing
quality-improvement programs to monitor and ensure com-
pliance with recommendations regarding antibiotic prophy-
laxis and maintenance of normoglycemia may prevent a subset
of these infections and improve outcomes for patients un-
dergoing spinal operations. n
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